Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
State's largest solar project provides clean, renewable energy and economic advantages
GUELPH, ON and JACKSON, Miss., May 27, 2022 /PRNewswire/ -- Canadian Solar Inc. ("Canadian
Canadian Solar (NASDAQ:CSIQ) reported its Q1 earnings results on Tuesday, May 24, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.